Issue 15, 2021

Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment

Abstract

Mitochondria play critical roles in the regulation of the proliferation and apoptosis of cancerous cells. Nanosystems for targeted delivery of cargos to mitochondria for cancer treatment have attracted increasing attention in the past few years. This review will summarize the state of the art of design and construction of nanosystems used for mitochondria-targeted delivery. The use of nanotechnology for cancer treatment through various pathways such as energy metabolism interference, reactive oxygen species (ROS) regulation, mitochondrial protein targeting, mitochondrial DNA (mtDNA) interference, mitophagy inducing, and combination therapy will be discussed. Finally, the major challenges and an outlook in this field will also be provided.

Graphical abstract: Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment

Article information

Article type
Minireview
Submitted
17 fev 2021
Accepted
03 abr 2021
First published
03 abr 2021

Nanoscale, 2021,13, 7108-7118

Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment

J. Qin, N. Gong, Z. Liao, S. Zhang, P. Timashev, S. Huo and X. Liang, Nanoscale, 2021, 13, 7108 DOI: 10.1039/D1NR01068A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements